Healthcare usage and expenditure among people with type 2 diabetes and/or hypertension in Cambodia: results from a cross-sectional survey.
General diabetes
HEALTH ECONOMICS
HEALTH SERVICES ADMINISTRATION & MANAGEMENT
Hypertension
Organisation of health services
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
12 01 2023
12 01 2023
Historique:
entrez:
12
1
2023
pubmed:
13
1
2023
medline:
17
1
2023
Statut:
epublish
Résumé
To assess usage of public and private healthcare, related healthcare expenditure, and associated factors for people with type 2 diabetes (T2D) and/or hypertension (HTN) and for people without those conditions in Cambodia. A cross-sectional household survey. Five operational districts (ODs) in Cambodia. Data were from 2360 participants aged ≥40 years who had used healthcare services at least once in the 3 months preceding the survey. The main variables of interest were the number of healthcare visits and healthcare expenditure in the last 3 months. The majority of healthcare visits took place in the private sector. Only 22.0% of healthcare visits took place in public healthcare facilities: 21.7% in people with HTN, 37.2% in people with T2D, 34.7% in people with T2D plus HTN and 18.9% in people without the two conditions (p value <0.01). For people with T2D and/or HTN, increased public healthcare use was significantly associated with Health Equity Fund (HEF) membership and living in ODs with Overall public healthcare usage was relatively low; however, it was higher in people with chronic conditions. HEF membership and
Identifiants
pubmed: 36635032
pii: bmjopen-2022-061959
doi: 10.1136/bmjopen-2022-061959
pmc: PMC9843177
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e061959Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
BMJ. 2018 Dec 7;363:k4698
pubmed: 30530736
Lancet. 2018 Mar 24;391(10126):1205-1223
pubmed: 29397200
Lancet. 2016 Aug 6;388(10044):540-1
pubmed: 27358254
PLoS One. 2016 Jan 27;11(1):e0146147
pubmed: 26815916
Health Policy Plan. 2021 Mar 3;36(1):26-34
pubmed: 33332527
Lancet. 2016 Aug 6;388(10044):596-605
pubmed: 27358253
PLoS One. 2020 Jun 25;15(6):e0235037
pubmed: 32584854
Lancet. 2016 Aug 6;388(10044):622-30
pubmed: 27358252
Health Policy Plan. 2004 Sep;19(5):310-21
pubmed: 15310666
Lancet. 2016 Aug 6;388(10044):606-12
pubmed: 27358251
Med Anthropol. 2020 Nov-Dec;39(8):765-781
pubmed: 32352869
PLoS One. 2017 Sep 25;12(9):e0181582
pubmed: 28945753
J Pharm Policy Pract. 2016 Jan 21;9:1
pubmed: 26798483
BMJ Open. 2019 Nov 21;9(11):e032578
pubmed: 31753894
BMJ Glob Health. 2019 Nov 13;4(6):e001679
pubmed: 31798986
Bull World Health Organ. 2007 Nov;85(11):880-5
pubmed: 18038079
Int J Equity Health. 2020 Sep 21;19(1):163
pubmed: 32958064